Aspire Biopharma Inc.

NASDAQ: ASBP · Real-Time Price · USD
0.55
0.01 (2.38%)
At close: Aug 22, 2025, 3:59 PM
0.51
-6.59%
After-hours: Aug 22, 2025, 07:57 PM EDT

Aspire Biopharma Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Net Income
-25.21M -9.44M -581.21K -403.12K -396.46K -232.59K -155.81K -90.27K
Depreciation & Amortization
n/a n/a n/a n/a n/a n/a n/a n/a
Stock-Based Compensation
14.13M n/a n/a n/a n/a n/a n/a n/a
Other Working Capital
571.73K 1.06M 255.95K 309.35K 355.13K 291.11K -126.98K 109.79K
Other Non-Cash Items
8.55M 8.08M -116.45K -116.45K -88.61K 4.5K 4.5K 4.5K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
665.62K 1.06M 255.95K 309.35K 355.13K 291.11K -126.98K 109.79K
Operating Cash Flow
-1.86M -303.44K -441.71K -210.21K -129.95K 63.02K -278.28K 24.02K
Capital Expenditures
-18.82K -18.82K -37.64K -18.82K -18.82K -18.82K n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
37.95K 18.82K -38.26K -38.26K -38.26K -19.13K 37.95K -19.13K
Investing Cash Flow
19.13K n/a -75.9K -75.9K -75.9K -56.77K 19.13K -19.13K
Debt Repayment
4.79M 1.97M 3.08M 2.59M n/a n/a n/a n/a
Common Stock Repurchased
-14.04M -14.04M -13.78M -298.7M -284.92M -284.92M -284.92M n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
12.1M 12.33M 11.18M 296.37M 285.15M 284.92M 285.18M n/a
Financial Cash Flow
3.12M 257.64K 481.3K 257.64K 229.08K n/a 268.82K n/a
Net Cash Flow
1.28M -27.14K -17.66K -9.82K 37.47K 1.36K 4.78K n/a
Free Cash Flow
-1.91M -265.19K -479.35K -70.48K 59.02K 164.5K -100.9K 24.02K